The video identifies three undervalued healthcare stocks: Eli Lilly (LLY), Novo Nordisk (NVO), and Pfizer (PFE). Eli Lilly is trading at a forward price to earnings of 27, Novo Nordisk at 15, and Pfizer at 8.5. Pfizer increased its revenue from 49 billion to 64 billion, spiking in 2020 due to the COVID vaccine, but has since crashed. Eli Lilly and Novo Nordisk have compounded annual growth rates of 11% and 12.8% respectively, outperforming Pfizer because of weight loss and diabetes treatments with upcoming oral pill versions. The video identifies the stocks as potential opportunities for long term investors.